0113 2727560

Contact Us

Contact CPWY

Twitter Latest Tweets

Latest PSNC News

Supply Notification: Berinert (Human C1 Esterase inhibitor) 500IU powder and solvent for injection (CSL Behring UK)

Department of Health and Social Care (DHSC) has issued a supply disruption notification for Berinert (Human C1 Esterase inhibitor) 500IU powder and solvent for injection as limited stock remains in the supply chain. Further information and management advice can be found in the alert. The DHSC Medicine Supply Team provide a monthly update on potential...

5 hours ago

Colestyramine sachets and Fluticasone nasules added to the list of medicines that cannot be parallel exported from the UK

Further to our news story Temporary parallel export ban issued to ensure continued supply of medicines the Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) has announced that Colestyramine sachets and Fluticasone nasules are to be added to the list of medicines which must not be parallel exported...

1 day ago

Class 2 Medicines recall: Ranitidine 150mg and 300mg Film-Coated Tablets (Accord Healthcare)

Drug alert number: EL (19)A/40 Date issued: 5 December 2019 Accord Healthcare are recalling all unexpired stock of the products listed below from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity Nnitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential. Product PL Number Ranitidine 150mg Film-Coated Tablets 20075/0063 Ranitidine 300mg...

1 day ago

Palliative Care Formulary Service

 

West Yorkshire-wide Palliative Care Formulary Service


West Yorkshire Palliative Care SLA

Appendix Two - Selection Criteria & EOI 

Appendix Three - Information Sheet for Healthcare Professionals

Appendix Four - PharmOutcomes - Instructions for Use 

Contact Details for Specialist Palliative Care Services


Pharmacies commissioned to provide this service stock a locally agreed list of medicines and make a commitment to ensure that the users of the service have prompt access to these medicines, in response to the presentation of an NHS prescription, during the pharmacies' contracted opening hours.

Please note: Other pharmacies will routinely stock many, if not all, of these drugs as part of their usual dispensary stock.

In the event of there being insufficient stock to fill an immediate need the pharmacy will liaise with another community pharmacy in the service with stock and/or other local community pharmacies.  The pharmacy will aim to locate a pharmacy with sufficient in-date stock and request that they reserve that stock for collection by the user.  If no further stock can be located the pharmacy will contact the prescriber to discuss a suitable alternative.

This service is available within the pharmacies opening hours only (available from NHS Choices www.nhs.uk).  Outside these hours requests should be directed to the Out of Hours Service Provider for the relevant area.

 

The previous service ended on 30th April 2018.   Please see Termination Letter below.

 Palliative Care - Termination Letter - 15th January 2018

  

 

Palliative Care - General

The novel “wheel” or “spider diagram” format of this guideline was developed by St Gemma’s Hospice over 15 years ago, to support

  • the safe conversion between different opioids
  • enable the safe administration of the same opioid by a different route
  •  to calculate and check the accuracy of “PRN” doses of opioids for patients receiving regular opioids

St Gemma’s clinical team, including Professor Michael Bennett, St Gemma’s Professor of Palliative Medicine, have updated the guideline in line with current company data and seminal specialist palliative care resources.

Although the current (2006) version of the guideline was never formally distributed to non-specialist palliative care providers across Leeds, many have a copy and have found it a useful resource.

The updated 2016 guideline is now approved for use by both specialist and non-specialist palliative care use across Leeds, supported by a project led by the Leeds Palliative Care Managed Clinical Network (MCN).

It is expected that non-specialists will predominantly continue to use the guide as a checking tool. If any discrepancies or queries arise during this checking process the prescriber must be contacted.

Prescribers are responsible for their own decisions. It is imperative to read the notes on the right hand side of the document and seek specialist palliative care advice as needed.

The Leeds Opioid Conversion Guide For Adult Palliative Care Patients 2016 is available as a PDF document on:

PLEASE REPLACE ANY PREVIOUS VERSIONS OF THE GUIDELINE WITH THIS 2016 UPDATE

Opioid Wheel

 

 

Resources / Guidance

 

 

Bradford



Calderdale

Guidance on Prescribing Anticipatory Drugs

Guidance on Prescribing Anticipatory Drugs - Patients with Advanced Kidney Disease

Guidance on Titrating Syringe Driver Medication


Kirklees



Leeds



Wakefield

Guidance on Prescribing Anticipatory Drugs and Syringe Drivers 

↑ Back to top

 

 

Last Updated: 25th April 2019